Macvan targeted by European top teams

Hemofarm's Milan Macvan is one of the most important and promising player in Europe. The power forward, according to Sportski žurnal has a proposal from Maccabi Tel Aviv which offers him a three year deal (€400.000 in the first season) and to Hemofarm €400.000 of buyout.

"All the European top teams are asking information on the player" said his agent Raskovic.

Marko Ivanovic, director of Hemofar, said that the future of the player, whose contract will expire at the end of the next season, will be discussed at the end of the year.

"Milan Macvan has a valid contract with us also for the coming season and to let him to leave we want a buyout. However, now it is too early to talk about him because the season is not over for us. Our goal is to confirm our best players and to be a better team next year" said Ivanovic.

Macvan, born in 1989, averaged 9.5ppg and 3.7rpg in Eurocup; 14.6ppg and 5.8rpg in Adriatic League; 14.9ppg and 6.2rpg in Serbian league.